Skip to main content
Clinical Trials/IRCT20200517047483N1
IRCT20200517047483N1
Not yet recruiting
Phase 2

The evaluation of effectiveness of Adjunctive use of sertraline on seizure improvement in patients with drug-resistant temporal lobe epilepsy

Shiraz University of Medical Sciences0 sites30 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Shiraz University of Medical Sciences
Enrollment
30
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Male / female (non\-pregnant female adequately protected from conception) patients, between ages 18 and 65 years
  • Patients with diagnosis of temporal lobe epilepsy
  • The patient made on the basis of clinical findings with drug\-resistant seizures defined as failure of two or more AEDs at maximal tolerated doses and one or more seizures per month
  • The patients have stable medication regimen for four weeks prior to entry

Exclusion Criteria

  • Patients with progressive neurological conditions
  • Patients with a history of non adherence for seizure diary completion or frequent clinic visits
  • Patients with a history of having any serious medical illness or major psychiatric disorder,
  • History of psychogenic nonepileptic seizures
  • History of suicidal attempt in the past five years any known
  • Pracense of contraindication for sertraline administration including: concomitant use in patients taking monoamine oxidase inhibitors (MAOIs) and hypersensitivity to sertraline
  • Taking any other medication with significant drug interaction with sertraline

Outcomes

Primary Outcomes

Not specified

Similar Trials